LATAM Pain Management Drugs Market (0220 to 2027) - by Drug Class ans Indication - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "LATAM Pain Management Drugs Market by Drug Class, Indication: Regional Opportunity Analysis and Industry Forecast, 2019-2027" report has been added to ResearchAndMarkets.com's offering.

The LATAM pain management drugs market was valued at $2,683. 82 million in 2019, and is projected to reach $3,383. 20 million by 2027, registering a CAGR of 3. 5% from 2020 to 2027.

Pain is a distressing sensory and emotional sensation, which is caused by tissue injury or disease. Moreover, different disorders may cause discomfort, such as multiple sclerosis, osteoarthritis, stomach ulcer, chronic arthritis, fibromyalgia, diabetic neuropathy, and cancer.

The length of pain ranges from acute pain for short term to chronic pain for long term. Acute pain is a sudden onset of pain while chronic pain is caused by aged bone & joint conditions, nerve damage, or injury. Pain management involves reducing or treating pain by using a given range of medications. There are several medicines available that provide pain relief through a variety of physiological mechanisms such as targeting nociceptors.

The rise in geriatric population is the major factor that drives growth of the LATAM pain management market, as aged people are more prone to suffer from joint pain and other chronic conditions. Moreover, surge in prevalence of chronic diseases, such as cancer, diabetic neuropathy, and osteoarthritis propels the market growth in Latin America. Furthermore, The rise in number of surgical procedures and The rise in healthcare expenditure are expected to fuel growth of the market. However, drug exploitation, patent expiration of prescription pain medication drugs, and availability of substitutes such as pain relief devices restrain the market growth in Latin America. The LATAM pain management drugs market is segmented on the basis of drug class, indication, and region. On the basis of drug class, the market is categorized into nonsteroidal anti-inflammatory drugs (NSAIDs), anesthetics, anticonvulsants, antimigraine agents, antidepressants, opioids, and nonnarcotic analgesics.

On the basis of indication, the market is divided into arthritic pain, neuropathic pain, cancer pain, chronic back pain, postoperative pain, migraine, fibromyalgia, bone fracture, muscle sprain, acute appendicitis, and others. By region, it is analyzed across Brazil, Argentina, Colombia, Peru, Chile, Ecuador, Panama, and rest of Latin America.

Key Benefits

• The study provides an in-depth analysis of the LATAM pain management drug market along with the current trends and future estimations to elucidate the imminent investment pockets.
• A comprehensive analysis of the factors that drive and restrict the market growth is provided in the report.
• The market forecast is studied from 2020 to 2027
• Comprehensive quantitative analysis of the industry from 2019 to 2027 is provided to enable the stakeholders to capitalize on the prevailing market opportunities.
• Extensive analysis of the key segments of the industry helps to understand the application and products of pain management used across the globe.
• Key market players and their strategies have been analysed to understand the competitive outlook of the market.

Market Dynamics

Drivers

• The Rise in Incidences of Chronic Diseases
• Favorable Regulatory Scenario
• Increase in Geriatric Population

Restraints

• Availability of Alternative Therapies
• Drug Exploitation
• Patent Expiration of Prescription Drugs

Opportunities

• Advancements in Drug Development
• Untapped Markets in Developing Economies

Key Players

• Abbott Laboratories
• Eli Lilly & Company
• GlaxoSmithKline Plc.
• Johnson & Johnson
• Merck & Co. Inc.
• Mylan NV.
• Novartis AG
• Pfizer, Inc.
• Axon
• Sanofi
• GRUNENTHAL

Other Prominent Players

• Allergen Inc.
• Bayer AG
• Bristol-Myers Squibb
• Boehringer Ingelheim
• Sorrento Therapeutics
• Valeant Pharmaceuticals International Inc.
• WEX Pharmaceuticals
• Zynerba Pharmaceuticals

For more information about this report visit https://www.researchandmarkets.com/r/q643wf